What products are included in the GHRP-6 category?
The category currently shows 1 in-stock GHRP-6 product from the real Egypt Peptides catalog, grouped across available concentrations, formats and companies.
Research peptides in Egypt
GHRP-6 in Egypt
GHRP-6 (growth hormone-releasing peptide-6) is a synthetic six-amino-acid peptide that acts on the ghrelin receptor (GHS-R1a) and stimulates growth hormone release. Egypt Peptides lists the available formats, concentrations and companies below. These are research peptides, supplied for laboratory research use only; this page gives no dosing or treatment guidance. Sourced research and regulatory information is in the Knowledge Hub.
1 products in stock1 listed companiesDelivery across Egypt
Also searched as: GHRP-6 · GHRP 6 · GHRP6 · Growth Hormone Releasing Peptide-6 · جي اتش ار بي 6
All listed GHRP-6 products
Compare every listed concentration, format and company, then open the product page to order.
1 products in stock
Research status
What the published research shows
A plain-language summary of the human studies, recorded adverse events and regulatory status, with a link to every source.
GHRP-6Limited human data
Growth hormone-releasing peptide-6: a synthetic six-amino-acid peptide that activates the ghrelin receptor (GHS-R1a) and triggers growth hormone release. Like ghrelin, it also increases appetite.
Regulatory statusNot authorised as a medicine. The US FDA keeps it in Category 2 of its compounding-risk list, and it is on the World Anti-Doping Agency prohibited list (S2.2.4).
Human studies
- Diagnostic study in 125 adults with pituitary disease and 125 healthy controls: researchers tested GHRP-6 given together with GHRH as a test for severe growth-hormone deficiency in adults, against the insulin tolerance test. Lancet 2000
Adverse events recorded
- The FDA cites a risk of immune reactions and possible rises in cortisol and blood glucose. FDA · compounding-risk list
Not yet establishedNo trial has shown a therapeutic benefit. The safety of repeated use and long-term effects on glucose and cortisol are unknown.
This is a research summary, not dosing or medical advice. The full study protocols, including every dose group, are in the linked sources. Findings describe the material used in each trial, not any specific product on sale; any use should be decided with a doctor.
Scientific background
Source-referenced research summary from the Egypt Peptides Knowledge Hub. It is not personal medical advice.
Explore related peptide categories
Egypt Peptides
IGF-1 LR3
IGF-1 LR3 is a synthetic analogue of insulin-like growth factor 1 with an extended
View category →Egypt PeptidesIpamorelin
Ipamorelin is a synthetic pentapeptide that acts on the ghrelin (GHS-R) receptor and is
View category →Egypt PeptidesKisspeptin
Kisspeptin (kisspeptin-10) is a synthetic fragment of the kisspeptin peptide that acts on
View category →Egypt PeptidesMOTS-C
MOTS-c is a 16-amino-acid peptide encoded by mitochondrial DNA that is studied in
View category →Egypt PeptidesNAD+
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme involved in cellular redox
View category →Egypt PeptidesPT-141
PT-141 (bremelanotide) is a synthetic melanocortin receptor agonist peptide.
View category →Why browse by peptide type?
Each category keeps concentrations, formats and companies together so you can compare the real catalog without losing the original product pages or checkout flow.
Current stock only
Products appear from the live catalog; no price, concentration or company is invented.
Arabic and English names
Each product is listed under its English and Arabic names and common spellings, so it is easy to find.
Research use only
Category copy avoids unsupported medical claims and keeps professional-use guidance visible.
Common questions
Can I compare different GHRP-6 companies and concentrations?
Yes. The category page keeps each real product card, company, concentration and current price visible before you open the original product page.
Are these products medical treatments?
No. Products and information are intended for research and professional use only. Category pages do not provide dosing, treatment guidance or medical advice.